MIST vs OKTA · rev $797.0K vs P/E 84, rev $1.57B
Milestone Pharmaceuticals Inc (MIST) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
MIST currently screens at market cap $160.6M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the MIST and OKTA stock pages for the full models.
Not investment advice.